• Wed. Aug 17th, 2022

VIVO Cannabis Subsidiary Canna Farms Granted Research License By Health Canada

ByVuk Zdinjak

Jul 22, 2022
VIVO Cannabis Subsidiary Canna Farms Granted Research License By Health Canada

Canna Farms a wholly-owned subsidiary of VIVO Cannabis Inc. VVCIF VIVO has received a research license from Health Canada allowing it to possess cannabis for the purpose of research. The research license allows Canna Farms to evaluate its medical cannabis products based on taste, smell, feel and visual appeal for research purposes prior to sales of these products.

“We are continually enhancing our product quality for our patients who rely on cannabis as medication,” stated Ray Laflamme, Canna Farms’ co-founder and VIVO’s chief executive officer. “This license allows us to understand the sensory characteristics of our cultivars in various product formats, and offers a competitive advantage for the new products and genetics we bring to market.”

The research license also allows Canna Farms to evaluate the products of strategic partners and third-party manufacturers sold on its curated medical e-commerce marketplace.

About VIVO Cannabis

VIVO Cannabis is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company has a collection of brands, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 200,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.

Photo by Louis Reed on Unsplash

Related News

VIVO Cannabis Stock Up On First Big Returns From Australian Business & 32% YoY 2020 Revenue Increase

Cicatrix Labs Teams Up VIVO Cannabis On Launch Of Assuage Brand Suppositories



Image and article originally from www.benzinga.com. Read the original article here.